» Articles » PMID: 18767000

The Completeness of the Swedish Cancer Register: a Sample Survey for Year 1998

Overview
Journal Acta Oncol
Specialty Oncology
Date 2008 Sep 4
PMID 18767000
Citations 421
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The Swedish Cancer Register (SCR) is used extensively for monitoring cancer incidence and survival and for research purposes. Completeness and reliability of cancer registration are thus of great importance for all types of use of the cancer register. The aim of the study was to estimate the overall coverage of malignant cancer cases in 1998 and to reveal possible reasons behind non-reporting.

Methods: We selected all malignant cancer cases in the Hospital Discharge Register (HDR) from 1998 and compared these records to those reported to the SCR. There were 43,761 discharges for 42,010 individuals of whom 3,429 individuals were not recorded in the SCR. From these 3 429 records we randomly selected 202 patients for review of their medical records to determine whether they should have been registered on the SCR as incident cases in 1998.

Results: About half of the 202 cases (93 malignant and 8 benign) should have been reported, which translates into an additional 1 579 malignant cases (95% CI 1 349-1 808), or 3.7% of the cases reported in 1998. The crude incidence rate for males and females combined would increase from 493 per 100,000 to 511 (95% CI 508-514) if these cases were taken into account.

Conclusion: The overall completeness of the SCR is high and comparable to other high quality registers in Northern Europe. For most uses in epidemiological or public health surveillance, the underreporting will be without major impact. However, for specific research questions our findings have implications, as the degree of underreporting is site specific, increases with age, and does not seem to be random, as diagnoses without histology or cytology verification are overrepresented. An annual comparison of the SCR against the HDR could point to hospitals, geographic areas or specific diagnoses where organizational and administrative changes should be introduced to improve reporting.

Citing Articles

Rising incidence trends of synchronous prostate and rectal cancers: a population-based study.

Edfelt E, Shahrivar M, Holmsten K, Radkiewicz C Acta Oncol. 2025; 64:374-379.

PMID: 40052250 PMC: 11905149. DOI: 10.2340/1651-226X.2025.42592.


Postoperative complications and health-related quality of life after oesophageal cancer surgery: a national, population-based cohort study.

Lagergren P, Johar A, Schandl A Acta Oncol. 2025; 63:974-981.

PMID: 39988754 PMC: 11697142. DOI: 10.2340/1651-226X.2024.41290.


Cohort Profile: The Northern Sweden Health and Disease Study (NSHDS).

Spath F, Wennberg P, Johansson R, Weinehall L, Norberg M, Rosen A Int J Epidemiol. 2025; 54(1).

PMID: 39899988 PMC: 11790227. DOI: 10.1093/ije/dyaf004.


Mortality in Autoimmune Liver Disease in Sweden: A Population-Based Cohort Study of 9,654 Patients.

Lasyte I, Widman L, Bergquist A, Hagstrom H Liver Int. 2025; 45(2):e70007.

PMID: 39840802 PMC: 11752691. DOI: 10.1111/liv.70007.


Cardiovascular health in breast cancer patients: insight on BRCA1/2 mutations impact.

Mallios P, Manshadi M, Hubbert L, Aydin T, Maes C, Rantala J Cardiooncology. 2025; 11(1):5.

PMID: 39838506 PMC: 11749121. DOI: 10.1186/s40959-025-00302-z.